Benjamin Walbaum: 14 Key Breast Cancer Studies and Updates From ESMO 2026
Benjamin Walbaum: 14 Key Breast Cancer Studies and Updates From ESMO 2026 Oncodaily
Benjamin Walbaum: 14 Key Breast Cancer Studies and Updates From ESMO 2026 Oncodaily
Клетки зомби после химиотерапии помогают опухоли выжить, но учёные нашли способ их уничтожить Правда.Ру
Having obesity in your 20s and 30s could raise your risk for early-onset cancer.
ESMO 2026 Highlights Developments in Breast Cancer Research Breast Cancer Research Foundation | BCRF
Bladder cancer treatment is changing fast. Can urologists keep up? MDLinx
Вакцина от рака удивила ученых - что удалось выяснить Cursorinfo
Osimertinib plus savolitinib reduced the risk for progression or death by 45% compared with chemotherapy for certain patients with locally advanced or metastatic non-small cell lung cancer, according to randomized phase 3 trial data. The findings, presented at European Society for Medical Oncology Congress, also…
Scientists Discover a Hidden Weakness in Cancer Cells That Could Transform Treatment SciTechDaily
Oncology PulsePoint: How NCCN Breast Cancer Updates Are Changing Testing and Treatment Pharmacy Times
PanCAN Marks Pancreatic Cancer Awareness Month with New Hope as Breakthroughs in Treatments Signal a New Era for Patients Pancreatic Cancer Action Network
Turning Cancer Research Into Action Through Storytelling and Strategic Communication - NCI Center for Global Health Oncodaily
Durvalumab Plus Enfortumab Vedotin Improves Survival in Bladder Cancer Oncology News Central
A combination cancer therapy that relies on the reactivation of a tumor suppressor protein to kill leukemic and other blood cancer cells has shown promise in a small pilot trial.
China’s innovative anti-cancer drugs highlighted at global oncology event Global Times